Study summary

In this study all patients will be treated with the same medicine, the QUTENZA patch. Subjects will receive up to 6 QUTENZA patch applications over 12 months.

Additional Study Details

Phase
4
Product
  • QUTENZA
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    306
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Safety and effectiveness of repeated administration of QUTENZA patches for treatment of pain caused by nerve damage? Contact us by filling out your information to the right and we’ll respond to you.

    • A caregiver
    • A healthcare provider
    • A parent
    • A patient
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      London, United Kingdom, SE1 7EH
      Completed
      Edegem, Belgium, 2650
      Completed
      Ferrol, Spain, 15405
      Completed
      Liverpool, United Kingdom, L97LJ
      Withdrawn
      Almada, Portugal, 2800-525
      Withdrawn
      Amadora, Portugal, 2700
      Completed
      Vienna, Austria, 1090
      Completed
      Helsinki, Finland, 00280
      Completed
      Roma, Italy, 00149
      Completed
      Naples, Italy, 80131
      Completed
      Antwerpen, Belgium, 2000
      Completed
      London, United Kingdom, E11BB
      Completed
      Rimini, Italy, 47900
      Completed
      Granada, Spain, 18014
      Completed
      Edinburgh, United Kingdom, EH4 2XU
      Completed
      London, United Kingdom, SW17 0QT
      Withdrawn
      Krakow, Poland, 31-531
      Completed
      Plzen-Lochotin, Czech Republic, 304 60
      Withdrawn
      Parma, Italy, 43100
      Withdrawn
      Valencia, Spain, 46014
      Completed
      Nice, France, 06002
      Withdrawn
      Athens, Greece, 11527
      Completed
      Warsawa, Poland, 00-416
      Completed
      Glasgow, United Kingdom, G12 0YN
      Completed
      Malaga, Spain, 29010
      Completed
      Solihull, United Kingdom, B91 2LJ
      Completed
      Rionero in Vulture, Italy, 85028
      Completed
      Tampere, Finland, 33100
      Completed
      Prague 5, Czech Republic, 150 06
      Completed
      Nieuwegein, Netherlands, 3435
      Withdrawn
      Wroclaw, Poland, 50-240
      Withdrawn
      Lodz, Poland, 90-238
      Withdrawn
      Coimbra, Portugal, 3000-075
      Completed
      Paris, France, 75012
      Completed
      Athens, Greece, 54642
      Completed
      Bratislava, Slovakia, 85107
      Completed
      Cork, Ireland
      Completed
      Roeselare, Belgium, 8800
      Completed
      Bydgoszcz, Poland, 85-094
      Completed
      Zwolle, Netherlands, 8011
      Completed
      Brno-Bohunice, Czech Republic, 625 00
      Completed
      Pavia, Italy, 27100
      Completed
      Boulogne Billancourt, France, 92100
      Completed
      Katowice, Poland, 40-662
      Completed
      Jesenice, Slovenia, 4270
      Completed
      Barakaldo, Spain, 48903
      Completed
      Taormina, Italy, 98039
      Completed
      Athens, Greece, 11528
      Completed
      Genk, Belgium, 3600
      Completed
      Saint - Etienne Cedex 2, France, 42055
      Completed
      Bucuresti, Romania
      Completed
      Badalona, Spain, 08025
      Completed
      Madrid, Spain, 28006
      Completed
      Barcelona, Spain, 08035
      Completed
      Ljubljana, Slovenia, 1000
      Completed
      Vienna, Austria, 1160
      Completed
      Cataluna, Spain, 8025
      Completed
      Prague, Czech Republic, 180 81
      Withdrawn
      Latina, Italy, 04100
      Completed
      Lodz, Poland, 94-238
      Completed
      Madrid, Spain, 28034
      Completed
      Palermo, Italy, 90146
      Completed
      Paris Cedex 13, France, 75651
      Withdrawn
      Lisbon, Portugal, 1150
      Completed
      London, United Kingdom, SW10 9NH
      Completed
      Paris, France, 75018
      Completed
      Barcelona, Spain, 8025
      Withdrawn
      Bratislava, Slovakia
      Completed
      Salamanca, Spain, 37007
      Completed
      Milan, Italy, 20132
      Completed
      Chieti, Italy, 66100
      Completed
      Brussels, Belgium, 1000
      Completed
      Dublin, Ireland, 9
      Completed
      Brighton, United Kingdom, BN2 1ES
      Withdrawn
      Tampere, Finland, 33520
      Completed
      Pecs, Hungary, 7623
      Completed
      Timisoara, Romania, 300723

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?